Castle Biosciences Inc. (CSTL)
NASDAQ: CSTL
· Real-Time Price · USD
20.11
0.29 (1.46%)
At close: Aug 15, 2025, 12:35 PM
Castle Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 346.27M | 347.08M | 332.07M | 311.88M | 287.59M | 250.72M | 219.79M | 192.01M | 167.52M | 152.22M | 137.04M | 123.74M | 110.2M | 98.12M | 94.08M | 86.34M | 78.09M | 68.04M |
Cost of Revenue | 68.31M | 65.41M | 65.6M | 64.51M | 60.22M | 54.05M | 47.65M | 42.08M | 39.62M | 36.25M | 32.01M | 27.09M | 22.73M | 18.74M | 15.82M | 13.9M | 11.87M | 10.32M |
Gross Profit | 277.96M | 281.68M | 266.47M | 247.37M | 227.37M | 196.68M | 172.13M | 149.93M | 127.91M | 115.98M | 105.03M | 96.65M | 87.48M | 79.39M | 78.26M | 72.45M | 66.21M | 57.72M |
Operating Income | -23.05M | -13.79M | 8.67M | -1.04M | -15.76M | -41.93M | -67.98M | -85.45M | -97.5M | -100.71M | -93.7M | -85.74M | -75.87M | -60.31M | -40.08M | -27.94M | -20.03M | -11.86M |
Interest Income | 12.82M | 13.02M | 12.92M | 12.66M | 12.03M | 11.28M | 10.62M | 9.78M | 8.3M | 6.27M | 3.97M | 1.71M | 440K | 94K | 68K | 70K | 65K | 79K |
Pretax Income | -10.25M | -2.22M | 21.56M | 11.14M | -4.02M | -30.66M | -57.37M | -75.39M | -88.76M | -73.61M | -68.9M | -63.5M | -55.04M | -60.22M | -40.01M | -29.66M | -22.46M | -15.05M |
Net Income | -9.47M | -5.07M | 18.25M | 6.08M | -3.1M | -30.8M | -57.47M | -75.5M | -87.41M | -70.28M | -65.7M | -51.51M | -44.49M | -51.63M | -31.29M | -29.75M | -22.55M | -15.13M |
Selling & General & Admin | 217.15M | 209.79M | 199.58M | 193.39M | 187.51M | 181.49M | 179.84M | 174.49M | 166.5M | 159.31M | 143M | 129.74M | 115.71M | 99.03M | 86.74M | 76.54M | 65.64M | 55.22M |
Research & Development | 49.38M | 50.64M | 51.51M | 52.74M | 53.34M | 52.6M | 53.53M | 51.93M | 49.92M | 48.53M | 44.9M | 43.04M | 39.63M | 34.5M | 29.65M | 24.78M | 20.34M | 16.25M |
Other Expenses | 34.49M | 35.03M | 6.71M | 2.27M | 2.27M | 4.52M | 6.74M | 8.96M | 8.99M | 8.84M | 10.83M | 14.22M | 12.61M | 10.77M | 6.55M | 950K | 256K | n/a |
Operating Expenses | 301.01M | 295.46M | 257.8M | 248.4M | 243.12M | 238.6M | 240.11M | 235.38M | 225.4M | 216.69M | 198.73M | 182.4M | 163.35M | 139.7M | 118.34M | 100.39M | 86.24M | 69.58M |
Interest Expense | 297K | 546K | 577K | 487K | 288K | 21K | 11K | 13K | 17K | 18K | 17K | 14K | 8K | 4K | 1K | 395K | 1.1M | 1.87M |
Selling & Marketing Expenses | 97.06M | 129.73M | 123.47M | 120.02M | 118.68M | 114.26M | 113.66M | 42.72M | 36.62M | 29.95M | n/a | 43.97M | 21.58M | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 369.32M | 360.87M | 323.4M | 312.92M | 303.35M | 292.65M | 287.76M | 277.46M | 265.02M | 252.93M | 230.74M | 209.48M | 186.07M | 158.44M | 134.16M | 114.28M | 98.11M | 79.91M |
Income Tax Expense | -781K | 2.85M | 3.32M | 5.06M | -918K | 132K | 101K | 119K | -1.35M | -3.32M | -3.2M | -11.99M | -10.53M | -8.56M | -8.69M | 116K | 111K | 106K |
Shares Outstanding (Basic) | 28.91M | 28.61M | 28.13M | 27.84M | 27.65M | 27.48M | 27.03M | 26.83M | 26.73M | 26.61M | 26.4M | 26.3M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
Shares Outstanding (Diluted) | 29.55M | 28.61M | 30.2M | 29.4M | 28.74M | 27.48M | 27.03M | 26.83M | 26.73M | 26.61M | 26.4M | 26.32M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
EPS (Basic) | -0.32 | -0.16 | 0.65 | 0.21 | -0.13 | -1.15 | -2.16 | -2.84 | -3.3 | -2.66 | -2.53 | -2 | -1.75 | -2.04 | -1.24 | -1.23 | -0.99 | -0.72 |
EPS (Diluted) | -0.35 | -0.19 | 0.62 | 0.20 | -0.14 | -1.15 | -2.16 | -2.84 | -3.29 | -2.65 | -2.52 | -1.99 | -1.75 | -2.04 | -1.24 | -1.22 | -0.98 | -0.71 |
EBITDA | 25.03M | 40.78M | 38.14M | 25.08M | 9.36M | -17.86M | -45.02M | -63.42M | -77.05M | -62.3M | -58.34M | -54.33M | -47.71M | -54.89M | -36.6M | -27.15M | -20.21M | -12.57M |
EBIT | -9.95M | -4.82M | 19M | 8.48M | -6.87M | -30.64M | -57.35M | -75.37M | -88.74M | -73.59M | -68.89M | -63.48M | -55.03M | -60.22M | -40.01M | -29.27M | -21.36M | -13.18M |
Depreciation & Amortization | 42.49M | 42.42M | 16M | 13.45M | 13.09M | 12.78M | 12.33M | 11.95M | 11.7M | 11.28M | 10.54M | 9.15M | 7.32M | 5.33M | 3.41M | 2.12M | 1.15M | 614K |